192 related articles for article (PubMed ID: 23131994)
1. Multiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesis.
Watson AP; Evans RL; Egland KA
Mol Cancer Res; 2013 Jan; 11(1):74-85. PubMed ID: 23131994
[TBL] [Abstract][Full Text] [Related]
2. SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer.
Hultgren EM; Patrick ME; Evans RL; Stoos CT; Egland KA
PLoS One; 2017; 12(5):e0177089. PubMed ID: 28475599
[TBL] [Abstract][Full Text] [Related]
3. SUSD2 Proteolytic Cleavage Requires the GDPH Sequence and Inter-Fragment Disulfide Bonds for Surface Presentation of Galectin-1 on Breast Cancer Cells.
Patrick ME; Egland KA
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387209
[TBL] [Abstract][Full Text] [Related]
4. SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer.
Cheng Y; Wang X; Wang P; Li T; Hu F; Liu Q; Yang F; Wang J; Xu T; Han W
Tumour Biol; 2016 Jul; 37(7):9919-30. PubMed ID: 26815503
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of sushi domain containing 2 is associated with progression of non-small cell lung cancer.
Cai C; Shi R; Gao Y; Zeng J; Wei M; Wang H; Zheng W; Ma W
Oncol Lett; 2015 Dec; 10(6):3619-3624. PubMed ID: 26788179
[TBL] [Abstract][Full Text] [Related]
6.
Sheets JN; Patrick ME; Egland KA
Oncotarget; 2020 Jun; 11(24):2290-2301. PubMed ID: 32595828
[TBL] [Abstract][Full Text] [Related]
7. Sushi Domain Containing 2 (SUSD2) inhibits platelet activation and binding to high-grade serous ovarian carcinoma cells.
Lager TW; Roetman JJ; Kunkel J; Thacker M; Sheets JN; Egland KA; Miles CM; Larson MK; Gubbels JAA
Platelets; 2018 Dec; 29(8):834-837. PubMed ID: 30335544
[TBL] [Abstract][Full Text] [Related]
8. Expression of sushi domain containing two reflects the malignant potential of gastric cancer.
Umeda S; Kanda M; Miwa T; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
Cancer Med; 2018 Oct; 7(10):5194-5204. PubMed ID: 30259711
[TBL] [Abstract][Full Text] [Related]
9. SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance.
Sheets JN; Iwanicki M; Liu JF; Howitt BE; Hirsch MS; Gubbels JA; Drapkin R; Egland KA
Oncogenesis; 2016 Oct; 5(10):e264. PubMed ID: 27775699
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma.
Liu XR; Cai CX; Luo LM; Zheng WL; Shi R; Zeng J; Xu YQ; Wei M; Ma WL
Cancer Cell Int; 2016; 16():15. PubMed ID: 26933386
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells.
Zhang S; Zeng N; Alowayed N; Singh Y; Cheng A; Lang F; Salker MS
PLoS One; 2017; 12(8):e0183681. PubMed ID: 28841682
[TBL] [Abstract][Full Text] [Related]
12. The Susd2 protein regulates neurite growth and excitatory synaptic density in hippocampal cultures.
Nadjar Y; Triller A; Bessereau JL; Dumoulin A
Mol Cell Neurosci; 2015 Mar; 65():82-91. PubMed ID: 25724483
[TBL] [Abstract][Full Text] [Related]
13. SUSD2 suppresses CD8
Zhao B; Gong W; Ma A; Chen J; Velegraki M; Dong H; Liu Z; Wang L; Okimoto T; Jones DM; Lei YL; Long M; Oestreich KJ; Ma Q; Xin G; Carbone DP; He K; Li Z; Wen H
Nat Immunol; 2022 Nov; 23(11):1588-1599. PubMed ID: 36266363
[TBL] [Abstract][Full Text] [Related]
14. ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties.
Rose AA; Annis MG; Dong Z; Pepin F; Hallett M; Park M; Siegel PM
PLoS One; 2010 Aug; 5(8):e12093. PubMed ID: 20711474
[TBL] [Abstract][Full Text] [Related]
15. SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer.
Xu Y; Miao C; Jin C; Qiu C; Li Y; Sun X; Gao M; Lu N; Kong B
Exp Cell Res; 2018 Feb; 363(2):160-170. PubMed ID: 29305171
[TBL] [Abstract][Full Text] [Related]
16. Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against Sushi domain containing 2.
Sivasubramaniyan K; Harichandan A; Schumann S; Sobiesiak M; Lengerke C; Maurer A; Kalbacher H; Bühring HJ
Stem Cells Dev; 2013 Jul; 22(13):1944-54. PubMed ID: 23406305
[TBL] [Abstract][Full Text] [Related]
17. Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.
Lombardo Y; Filipović A; Molyneux G; Periyasamy M; Giamas G; Hu Y; Trivedi PS; Wang J; Yagüe E; Michel L; Coombes RC
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16558-63. PubMed ID: 23012411
[TBL] [Abstract][Full Text] [Related]
18. Loss of SUSD2 expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma.
Guo W; Shao F; Sun S; Song P; Guo L; Xue X; Zhang G; Zhang H; Gao Y; Qiu B; Tan F; Gao S; He J
J Cancer; 2020; 11(7):1648-1656. PubMed ID: 32194777
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.
Mahauad-Fernandez WD; DeMali KA; Olivier AK; Okeoma CM
Breast Cancer Res; 2014 Dec; 16(6):493. PubMed ID: 25499888
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in SUSD2 are associated with the risk of ischemic heart disease.
Bruikman CS; Dalila N; van Capelleveen JC; Kroon J; Peter J; Havik SR; Willems M; Huisman LC; de Boer OJ; Hovingh GK; Tybjaerg-Hansen A; Dallinga-Thie GM
J Clin Lipidol; 2020; 14(4):470-481. PubMed ID: 32620384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
